DERMATOLOGY: Edited by Joyce M. C. TengUpdate in the management of pediatric psoriasisTangtatco, Jennifer Aileen Anga; Lara-Corrales, Irenea,bAuthor Information aSection of Dermatology, Division of Paediatric Medicine, The Hospital for Sick Children bDepartment of Paediatrics, University of Toronto, Toronto, Ontario, Canada Correspondence to Irene Lara-Corrales, MD, MSc, Section of Dermatology, Division of Paediatric Medicine, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada. Tel: +1 416 8137564; e-mail: firstname.lastname@example.org Current Opinion in Pediatrics: August 2017 - Volume 29 - Issue 4 - p 434-442 doi: 10.1097/MOP.0000000000000517 Buy Metrics Abstract Purpose of review Psoriasis is a multifactorial, chronic, inflammatory skin disease that may represent a therapeutic challenge in children. This review aims to provide a framework for the management of pediatric psoriasis, emphasizing in new insights and considerations for management. It will focus on new disease associations and innovative treatment modalities that challenge current approach of psoriasis in children. Recent findings There is an increasing body of literature both in adults and in children linking psoriasis with different comorbidities. This new evidence points to the need of addressing psoriasis as a systemic disease and suggests the need for screening and creating awareness of possible associations. In a similar manner, newer medications are also being investigated in children. Recent publications report on the efficacy and safety of biologics for psoriasis in pediatric patients. Summary The review provides better understanding of present and future risks of untreated and uncontrolled psoriasis in children and at the same time the benefits and risks of new treatments available. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.